Adamantane-1,3-diamine | CAS 10303-95-4 - Request Quote
Adamantane-1,3-diamine
| SZ CAT No: | SZ-A015046 |
| CAS No | 10303-95-4 |
| Mol.F. | C10H18N2 |
| Mol.Wt. | 166.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 169565-60-0 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Adamantane-1,3-diamine is chemically (1s,3s,5s,7s)-adamantane-1,3-diamine. Adamantane-1,3-diamine is supplied with detailed characterization data compliant with regulatory guideline. Adamantane-1,3-diamine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amantadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 10303-95-4
Purchase 10303-95-4
Order 10303-95-4
Enquire 10303-95-4
price of 10303-95-4
10303-95-4 Supplier
10303-95-4 Manufacturer
10303-95-4 Exporter
buy high quality Adamantane-1,3-diamine
Purchase Adamantane-1,3-diamine
Adamantane-1,3-diamine suppliers
Adamantane-1,3-diamine manufacturers
Adamantane-1,3-diamine price
Order Adamantane-1,3-diamine
Enquire Adamantane-1,3-diamine
Adamantane-1,3-diamine cost
Adamantane-1,3-diamine Supplier
Adamantane-1,3-diamine Distributor
Adamantane-1,3-diamine for Method Validation
Amantadine Reference Standard
Adamantane-1,3-diamine for ANDA Filing
Adamantane-1,3-diamine for Forced Degradation Studies
Adamantane-1,3-diamine Identification Standards
Adamantane-1,3-diamine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


